This assay is to provide Daudi-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Daudi
Target Cell Organism
Human
Target Cell Background
The Daudi cell line is composed of B lymphoblasts isolated from the peripheral blood of a Black,16-year-old, male, Burkitt's Lymphoma patient in 1967. These well-characterized B lymphoblasts have been extensively used in the study of leukemogenesis.
Related Diseases
Burkitt's Lymphoma
Research Area
Oncology
Assay Name
In Vivo Tumorigenesis Assay
Short Description
Daudi-cell based In Vivo Tumorigenesis Assay
Assay Description
Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.